As a result, IV estimates of LATE for ACE/ARB use on 1-year survival for post-AMI patients should fall between the RCT estimates described previously. In addition, all else equal, if essential heterogeneity is occurring we expect that LATE estimates will be biased high and that the bias ...
which are recorded in ~ 40% of critically ill COVID-19 patients. Neurodegeneration (ND) is one of the most serious complications. It is necessary to understand its molecular mechanism(s), define research gaps to direct research to, hopefully, design new treatment modalities, for predictive...
Symptoms such as headache, confusion, twitching, irritability, hypertension, bounding pulses, increased central venous pressures, and jugular venous distention (JVD) are often noted in hypotonic patients. IV therapies for patients with fluid and electrolyte imbalances Highlights at the Jampro stand will...